DELAYED UPDATE — UBS raises JNJ price target to $320 ahead of Q3 results
Johnson & Johnson will release Q3 results Oct. 13, with a 6:45 a.m. ET press release and 8:30 a.m. ET earnings call/webcast. UBS raised its price target to $320 from $280.
Johnson & Johnson (NYSE:JNJ) will release Q3 results Oct. m. m. ET earnings call/webcast featuring the CEO and CFO.
UBS raised its price target to $320 from $280, sending JNJ shares higher and lifting the healthcare sector and the Dow.